The company's next-generation sequencing-based test is used to aid the detection of cancers in patients with indeterminate lesions.

Although treatment with high-dose corticosteroids can reduce mast burden and improve symptoms such as pain, congestive heart failure, and cytopenia in patients with MCL, their effects are frequently ...

The Global Genotyping Market is estimated to be valued at approximately USD 2.42 billion in 2023 and is expected to grow at a robust CAGR of 14.59% over the forecast period 2024-2032. Request To ...

The rapid identification of respiratory virus outbreaks is needed to enable rational and effective public health interventions. We developed new quantitative approaches for simultaneous ...

NEW YORK, July 7, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global mRNA ...

The global Liquid Biopsy Market is valued at USD 11.41 Billion in 2024 and is projected to reach a value of USD 30.65 Billion ...

The global Metagenomics Market is estimated to be valued at USD 231.1 million in 2025 and is projected to reach USD 442.07 million by 2035, registering a CAGR of 6.7% over the forecast period. The ...

According to Future Market Insights (FMI), the global Dual Biomarker Assays Market is expected to grow significantly in the coming years. But let’s be clear: growth projections mean nothing if the ...

Introduction In vitro diagnostics (IVD) refers to medical tests performed outside the human body, typically in laboratories or at the point of ...